Clinical Trial Update: iCLAS™ for Persistent Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial NCT04061603 evaluating iCLAS for persistent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• iCLAS

Snippet

Sponsor: Adagio Medical | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED